An introduction to pharmacovigilance / (Record no. 12869)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01413nam a2200229Ia 4500 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | NULRC |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250520102657.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 250520s9999 xx 000 0 und d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9781405194716 |
040 ## - CATALOGING SOURCE | |
Transcribing agency | NULRC |
050 ## - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RM 302.5 .W35 2010 |
100 ## - MAIN ENTRY--PERSONAL NAME | |
Personal name | Waller, Patrick |
Relator term | author |
245 #3 - TITLE STATEMENT | |
Title | An introduction to pharmacovigilance / |
Statement of responsibility, etc. | Patrick Waller |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Place of publication, distribution, etc. | Chichester, England : |
Name of publisher, distributor, etc. | John Wiley & Son, Inc., |
Date of publication, distribution, etc. | c2010 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | xiii, 106 pages : |
Other physical details | illustrations ; |
Dimensions | 22 cm. |
365 ## - TRADE PRICE | |
Price amount | USD31.23 |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc. note | Includes index. |
505 ## - FORMATTED CONTENTS NOTE | |
Formatted contents note | What is pharmacovigilance and how has it developed? -- Basic concepts -- Types and sources of data -- The process of pharmacovigilance -- Regulatory aspects of pharmacovigilance -- International collaboration -- Ethical and societal considerations -- Future directions -- Learning more about pharmacovigilance |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems. This introductory guide is designed to aid the rapid understanding of the key principles of pharmacovigilance. Packed full of examples illustrating drug safety issues it not only covers the processes involved, but the regulatory aspects and ethical and societal considerations of pharmacovigilance. |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | DRUGS -- SIDE EEFECTS |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | Library of Congress Classification |
Koha item type | Books |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection | Home library | Current library | Shelving location | Date acquired | Source of acquisition | Cost, normal purchase price | Total checkouts | Full call number | Barcode | Date last seen | Copy number | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Library of Congress Classification | Pharmacy | LRC - Main | National University - Manila | General Circulation | 03/28/2016 | Purchased - Amazon | 31.23 | GC RM 302.5 .W35 2010 | NULIB000010628 | 05/20/2025 | c.1 | 05/20/2025 | Books |